Investing Profile

Ming Cheah

Advisor
Biotech Investor at Goldman Sachs
San Francisco Bay Area
Photo of Ming Cheah, Goldman Sachs

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Goldman Sachs Network
1015 CONNECTIONS
Goldman Sachs Network
1015 CONNECTIONS
Mckinsey & Company Network
693 CONNECTIONS
Yale University Network
409 CONNECTIONS
Genentech Network
72 CONNECTIONS
Pivotal bioVenture Partners Principal
$39.9B
Postdoctoral Associate and Graduate Researcher Stanford University School of MedicinePresent
Postdoctoral Associate and Graduate Researcher Stanford Center for Clinical Research (SCCR)Present
Consultant Mckinsey & CompanyPresent
Business Development and Competitive Intelligence GenentechPresent
Consultant IndependentPresent
Principal Pivotal Life SciencesPresent
Board Observer HotSpot Therapeutics, Inc.Present
Board Observer Avalyn Pharma Inc.Present
Vice President - Life Sciences Investing Goldman SachsPresent
Board Observer PlexiumPresent
Board Observer Avalyn PharmaPresent
Biotech Investor Goldman SachsPresent
Board Observer TORL BioTherapeutics, LLCPresent
Board Observer SepternaPresent
Board Observer TORL BioTherapeutics LLCPresent
Board Observer Attovia TherapeuticsPresent
Member Board of Directors Ajax TherapeuticsPresent
Member Board of Directors Newleos TherapeuticsPresent
Principal Pivotal bioVenture Partners2020 - 2022
Yale University Bachelor of Science (B.S.); Master of Science (M.S.) Biology
Stanford University School of Medicine Doctor of Philosophy (Ph.D.) Immunology & Oncology
Stanford University School of Medicine Doctor of Philosophy (Ph.D.) Immunology
Sign in with Google →
Sign in with Google →